Skip to main content

Table 1 Baseline characteristics of patients with ARDS and control subjects

From: Prognostic value of secretory autophagosomes in patients with acute respiratory distress syndrome

Variables

ARDS (nā€‰=ā€‰46)

Controls (nā€‰=ā€‰8)

P value

Age (year)

58.50 [49.25-71.00]

37.50 [31.50-48.75]

0.005

Male, n (%)

32 (69.6)

8 (100.0)

0.095

Cause of ARDS, n (%)

Ā Ā Ā 

ā€¢ Direct ARDS

ā€¢ Indirect ARDS

39 (84.8%)

7 (15.2%)

Ā Ā 

Risk factor for ARDS, n (%)

Ā Ā Ā 

ā€¢ Pneumonia

ā€¢ Sepsis

ā€¢ Pulmonary contusion

ā€¢ pancreatitis

ā€¢ Other

27 (58.6%)

3 (6.5%)

9 (19.5%)

3 (6.5%)

4 (8.9)

Ā Ā 

Comorbidities, n (%)

Ā Ā Ā 

ā€¢ Diabetes

5(10.9)

0(0.0)

1.000

ā€¢ Hypertension

18(39.1)

4(50.0)

0.702

ā€¢ Cardiovascular disease

7(15.2)

0(0.0)

0.540

ā€¢ Cerebrovascular disease

25(54.3)

1(12.5)

0.052

ā€¢ Urinary system disease

8(17.4)

0(0.0)

0.460

ā€¢ Digestive system disease

13(28.3)

0(0.0)

0.201

APACHE II score

22.39ā€‰Ā±ā€‰7.15

6.50ā€‰Ā±ā€‰3.12

<ā€‰0.001

SOFA score

9.52ā€‰Ā±ā€‰3.66

1.5ā€‰Ā±ā€‰1.20

<ā€‰0.001

Mechanical ventilation setting

Ā Ā Ā 

ā€¢ Tidal volume (ml)

400.00[342.50ā€“420.00]

450.00[427.50ā€“460.00]

0.001

ā€¢ PEEP (cm H2O)

10.00[6.75-12.00]

5.00

<ā€‰0.001

ā€¢ PaO2/FiO2 (mm Hg)

155.63ā€‰Ā±ā€‰63.03

321.43ā€‰Ā±ā€‰79.27

<ā€‰0.001

Laboratory variables

Ā Ā Ā 

ā€¢ Plasma creatinine (umoL/L)

78.00[52.50ā€“104.00]

79.50[70.25-84.00]

0.79

ā€¢ White blood cell count (109/L)

12.81[9.39ā€“16.18]

6.56[5.39ā€“7.56]

0.003

ā€¢ Hemoglobin (g/L)

91.86ā€‰Ā±ā€‰25.75

148.63ā€‰Ā±ā€‰9.38

<ā€‰0.001

ICU stay (day)

18.00[8.00ā€“33.00]

1

<ā€‰0.001

  1. The data are presented as the meanā€‰Ā±ā€‰standard deviation or as the median [interquartile range]. P values less than 0.05 were considered statistically significant. APACHE, acute physiology and chronic health evaluation; ARDS, acute respiratory distress syndrome; ICU, intensive care unit; PaO2/FiO2, the ratio of partial pressure of oxygen of fractional inspired oxygen; PEEP, positive end-expiratory pressure; SOFA, sequential organ failure assessment